These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38940998)

  • 1. Major adverse kidney events in multidisciplinary chronic kidney disease care compared with usual outpatient care: a propensity score matched analysis.
    Chittinandana P; Gojaseni P; Chuasuwan A; Singprasert R; Chailimpamontree W; Chittinandana A
    J Nephrol; 2024 Jun; ():. PubMed ID: 38940998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease.
    Idris I; Zhang R; Mamza JB; Ford M; Morris T; Banerjee A; Khunti K
    Diabetes Obes Metab; 2022 Nov; 24(11):2138-2147. PubMed ID: 35676798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
    Chen S; Chen L; Jiang H
    Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient multidisciplinary care can prevent deterioration of renal function in patients with chronic kidney disease: a nationwide cohort study.
    Abe M; Hatta T; Imamura Y; Sakurada T; Kaname S
    Front Endocrinol (Lausanne); 2023; 14():1180477. PubMed ID: 37409235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
    Wheeler DC; Stefánsson BV; Jongs N; Chertow GM; Greene T; Hou FF; McMurray JJV; Correa-Rotter R; Rossing P; Toto RD; Sjöström CD; Langkilde AM; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):22-31. PubMed ID: 33338413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and Renal Outcomes in an Excellent Chronic Kidney Disease Clinic Compared with an Outpatient Clinic in a Primary Care Setting: A Retrospective Cohort Study.
    Aiumtrakul N; Euswas K; Phichedwanichskul K; Rangsin R; Kaewput W; Satirapoj B
    Kidney Dis (Basel); 2019 Jun; 5(3):144-152. PubMed ID: 31259176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD.
    Jung CY; Heo GY; Park JT; Joo YS; Kim HW; Lim H; Chang TI; Kang EW; Yoo TH; Kang SW; Lee J; Kim SW; Oh YK; Jung JY; Oh KH; Ahn C; Han SH
    Clin Res Cardiol; 2021 Jul; 110(7):1116-1127. PubMed ID: 34003323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.
    Chen PM; Lai TS; Chen PY; Lai CF; Yang SY; Wu V; Chiang CK; Kao TW; Huang JW; Chiang WC; Lin SL; Hung KY; Chen YM; Chu TS; Wu MS; Wu KD; Tsai TJ
    Am J Med; 2015 Jan; 128(1):68-76. PubMed ID: 25149427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate.
    Jairoun AA; Ping CC; Ibrahim B
    Sci Rep; 2024 Apr; 14(1):9014. PubMed ID: 38641627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of weight loss on the estimated glomerular filtration rates of obese patients at risk of chronic kidney disease: the RIGOR-TMU study.
    Lin YC; Lai YJ; Lin YC; Peng CC; Chen KC; Chuang MT; Wu MS; Chang TH
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):756-766. PubMed ID: 30938491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synergistic effect of variability in estimated glomerular filtration rate with chronic kidney disease on all-cause mortality prediction in patients with type 2 diabetes: a retrospective cohort study.
    Chang YS; Li YH; Lee IT
    Cardiovasc Diabetol; 2021 Oct; 20(1):209. PubMed ID: 34663321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and current status of multidisciplinary care for patients with chronic kidney disease in Japan: a nationwide multicenter cohort study.
    Abe M; Hatta T; Imamura Y; Sakurada T; Kaname S
    Clin Exp Nephrol; 2023 Jun; 27(6):528-541. PubMed ID: 37002509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.